Skip to main content
Clinical Trials/CTRI/2024/05/067169
CTRI/2024/05/067169
Not Yet Recruiting
Phase 4

Evaluation of Efficacy and Safety of Integrative Therapy of Drakshavaleha with Oral Iron FolicAcid Supplements in Management of Mild to Moderate Iron Deficiency Anaemia: A Randomized Controlled Trial - NI

Indian Council of Medical Research0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: D509- Iron deficiency anemia, unspecified
Sponsor
Indian Council of Medical Research
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1 Women of reproductive age group (18 to 49 years) with mild (Hb 11\-11\.9\) to moderate (Hb 8 to 10\.9 g/dL) anemia
  • 2 Serum ferritin less than 30 mcg/dL
  • 3 Should consent to receive any type of intervention before randomization.
  • 4 Not participating in any other research study

Exclusion Criteria

  • 1 Pregnant and lactating women
  • 2 Known cases of anemia due to other causes (Sickle cell anemia; Thalassemia minor)
  • 3 Those who are already consuming IFA greater than 14 days
  • 4 HbA1C greater than 6\.5%
  • 5 Known Diabetics on regular medicines
  • 6 Known allergy to iron and ingredients of Drakshavaleha
  • 7 Patient with known chronic kidney and liver disease
  • 8 Any other condition in the advice of the treating doctor that is putting the participant on risk due to study participation

Outcomes

Primary Outcomes

Not specified

Similar Trials